Treatment of intracoronary thrombus in the catheterisation laboratory in acute coronary syndrome patients;Traitement du thrombus dans les syndromes coronaires aigus en salle de cardiologie interventionnelle

Annales de Cardiologie et d'Angeiologie

Volumn 56, Issue 6, 2007, Pages 250-256

  Collet, J P ^a   Beygui, F ^a   Barthelemy O ^a   Livarek, B ^a   Montalescot, G ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Acute coronary syndrome; Glycoprotein IIb IIIa inhibitors; Intracoronary thrombus; Thrombectomy

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; IODIXANOL; LYSINE ACETYLSALICYLATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ACUTE CORONARY SYNDROME; BLEEDING; GOLD STANDARD; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; SHORT SURVEY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBECTOMY; THROMBUS; TREATMENT INDICATION; ARTICLE; CORONARY ARTERY THROMBOSIS; DRUG ANTAGONISM; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY THROMBOSIS; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RISK ASSESSMENT; STENTS; THROMBECTOMY; TREATMENT OUTCOME;

EID: 36248960648     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2007.10.003     Document Type: Short Survey

References (12)

1. Montalescot G., and RIVIERA Investigators. Registry on intravenous anticoagulation in the elective and primary real world of angioplasty. EHJ (2006) (XXII congress of the European Society of Cardiology, Barcelona, Spain) (Abstract)
2. Montalescot G., Sideris G., Meuleman C., Bal-dit-Sollier C., Lellouche N., Steg P.G., et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the best loading dose of clopidogrel to blunt platelet activation, inflammation and ongoing necrosis) trial. J. Am. Coll. Cardiol. 48 5 (2006) 931-938
3. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernandez-Aviles F., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur. Heart J. 28 13 (2007) 1598-1660
4. Kastrati A., Mehilli J., Neumann F.J., Dotzer F., Ten Berg J., Bollwein H., et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized Trial. JAMA 295 (2006) 1531-1538
5. Le Feuvre C., Batisse A., Collet J.P., Batisse J.P., Choussat R., Beygui F., et al. Cardiac events after low osmolar ionic or isosmolar non-ionic contrast media utilization in the current era of coronary angioplasty. Catheter Cardiovasc. Interv. 67 6 (2006) 852-858
6. Montalescot G., White H.D., Gallo R., Cohen M., Steg P.G., Aylward P.E., et al., STEEPLE investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N. Engl. J. Med. 355 (2006) 1006-1017
7. Montalescot G., Antoniucci D., Kastrati A., Neumann F.J., Borentain M., Migliorini A., et al. Bciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up. Eur. Heart J. 28 4 (2007) 443-449
8. Antman E.M., Morrow D.A., McCabe C.H., Murphy S.A., Ruda M., Sadowski Z., et al., for the ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-Elevation myocardial infarction. N. Engl. J. Med. 354 (2006) 1524-1527
9. Gershlick A.H., Stephens-Lloyd A., Hughes S., Abrams K.R., Stevens S.E., Uren N.G., et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med. 353 (2006) 2758-2768
10. ASSENT-4 PCI Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction ASSENT-4 PCI randomised trial (Assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention). Lancet 367 (2006) 569-578
11. Stone G.W., Webb J., Cox D., Brodie B., Qureschi M.A., Dulas D., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. Jama 293 9 (2005) 1063-1072
12. Smith Jr. S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372